ranolazine has been researched along with Diabetes Mellitus, Adult-Onset in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (8.33) | 29.6817 |
| 2010's | 18 (75.00) | 24.3611 |
| 2020's | 4 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Eaton, F; Gopal, K; Greenwell, AA; Saed, CT; Tabatabaei Dakhili, SA; Ussher, JR | 1 |
| Armentaro, G; Cassano, V; Citraro, R; De Sarro, C; De Sarro, G; Hribal, ML; Iannone, M; Leo, A; Russo, E; Sciacqua, A; Tallarico, M | 1 |
| Aldasoro, C; Aldasoro, M; Arias-Mutis, OJ; Guerra-Ojeda, S; Jorda, A; Valles, SL; Vila, JM | 1 |
| Janardanan Subramonia, K; Karunanidhi Santhana, L; Ravula, SR; Thangavel Mahalingam, V | 1 |
| Branstetter, J; Gilbert, BW; Huffman, J; Little, L; Meister, A; Sherard, M | 1 |
| Coleman, CI; Kohn, CG; Nguyen, E; Weeda, ER | 1 |
| Arnold, SV; Belardinelli, L; Ben-Yehuda, O; Chaitman, BR; Jones, PG; Katz, A; Kosiborod, M; Li, Y; McGuire, DK; Olmsted, A; Spertus, JA; Yue, P | 1 |
| DeMaria, AN; Lew, WY | 1 |
| Geunes-Boyer, S; Hines, ME; Kloner, RA | 1 |
| Galderisi, M; Mafrici, A | 1 |
| Arnold, SV; Ben-Yehuda, O; Kosiborod, M; Li, Y; McGuire, DK; Spertus, JA; Yue, P | 1 |
| Arnold, SV; Belardinelli, L; Jones, PG; Kosiborod, M; Li, Y; Spertus, JA; Yue, P | 1 |
| Arnold, SV; Belardinelli, L; Ben-Yehuda, O; Chaitman, BR; Jones, PG; Kosiborod, M; Li, Y; McGuire, DK; Olmsted, A; Spertus, JA; Yue, P | 1 |
| Amaral, N; Okonko, DO | 1 |
| Belardinelli, L; Dhalla, A; Eckel, RH; Henry, RR; Jochelson, P; Skyler, JS; Wong, P; Yue, P | 1 |
| Ghushchyan, V; Hartsfield, CL; Koch, BR; Nair, KV; Page, RL; Read, RA | 1 |
| Arnold, SV; Belardinelli, L; Chaitman, BR; Inzucchi, SE; Kosiborod, M; McGuire, DK; Spertus, JA; Tang, F; Yue, P | 1 |
| Belardinelli, L; Dhalla, A; Eckel, RH; Guan, S; Henry, RH; Jochelson, P; McNabb, B; Pettus, J; Skyler, JS | 1 |
| Brenner, M; Greiner, L; Hurren, K | 1 |
| Allard, M; Ben-Yehuda, O; Berg, J; Gottwald, M; Jochelson, P; Juan, A; Pannacciulli, N; Shao, Y; Zack, J; Zhang, H | 1 |
| Battaglia, D; Caminiti, G; Fossati, C; Massaro, R; Rosano, G; Volterrani, M | 1 |
| Crea, F; Di Franco, A; Ghirlanda, G; Lamendola, P; Lanza, GA; Nerla, R; Pitocco, D; Russo, G; Scavone, G; Sestito, A; Stazi, A; Villano, A | 1 |
| Marazzi, G; Rosano, GM; Volterrani, M | 1 |
| Bhandari, B; Subramanian, L | 1 |
5 review(s) available for ranolazine and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Antihyperglycemic and Metabolic Effects of Ranolazine in Patients With Diabetes Mellitus.
Topics: Adolescent; Cardiovascular Agents; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Ranolazine | 2018 |
Efficacy and safety of ranolazine in patients with chronic stable angina.
Topics: Acetanilides; Angina, Stable; Arrhythmias, Cardiac; Diabetes Mellitus, Type 2; Drug Interactions; Electrocardiography; Enzyme Inhibitors; Geriatrics; Glycated Hemoglobin; Humans; Piperazines; Randomized Controlled Trials as Topic; Ranolazine | 2013 |
Metabolic abnormalities of the heart in type II diabetes.
Topics: Antioxidants; Cardiovascular Agents; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Energy Metabolism; Fatty Acids; Glucose; Humans; Mitochondria, Heart; Myocardium; Organophosphorus Compounds; Oxidative Phosphorylation; Oxidative Stress; Perhexiline; Ranolazine; Trimetazidine; Ubiquinone | 2015 |
Ranolazine and Its Effects on Hemoglobin A1C.
Topics: Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Randomized Controlled Trials as Topic; Ranolazine | 2016 |
Ranolazine, a partial fatty acid oxidation inhibitor, its potential benefit in angina and other cardiovascular disorders.
Topics: Acetanilides; Angina Pectoris; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Fatty Acids; Heart Failure; Humans; Oxidation-Reduction; Piperazines; Ranolazine | 2007 |
10 trial(s) available for ranolazine and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Effect of ranolazine as add-on therapy in type 2 diabetic dyslipidaemia patients: A randomised open-label trial.
Topics: Acetanilides; Diabetes Mellitus, Type 2; Dyslipidemias; Humans; Ranolazine | 2021 |
Evaluation of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina: results from the TERISA randomized clinical trial (Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina).
Topics: Acetanilides; Aged; Angina, Stable; Coronary Artery Disease; Diabetes Mellitus, Type 2; Double-Blind Method; Enzyme Inhibitors; Female; Glycated Hemoglobin; Humans; Male; Middle Aged; Nitroglycerin; Piperazines; Ranolazine; Sodium Channel Blockers; Treatment Outcome; Vasodilator Agents | 2013 |
Effects of ranolazine on quality of life among patients with diabetes mellitus and stable angina.
Topics: Acetanilides; Aged; Angina, Stable; Diabetes Mellitus, Type 2; Double-Blind Method; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Nitroglycerin; Patient Satisfaction; Piperazines; Quality of Life; Ranolazine; Treatment Outcome; Vasodilator Agents | 2014 |
Comparison of the Seattle Angina Questionnaire With Daily Angina Diary in the TERISA Clinical Trial.
Topics: Acetanilides; Angina Pectoris; Coronary Artery Disease; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Enzyme Inhibitors; Follow-Up Studies; Humans; Incidence; Medical Records; Piperazines; Prospective Studies; Ranolazine; Surveys and Questionnaires; Treatment Outcome; United States | 2014 |
Effectiveness of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina according to baseline hemoglobin A1c.
Topics: Acetanilides; Angina, Stable; Chronic Disease; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Enzyme Inhibitors; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Male; Middle Aged; Piperazines; Ranolazine; Retrospective Studies; Treatment Outcome | 2014 |
Effect of Ranolazine Monotherapy on Glycemic Control in Subjects With Type 2 Diabetes.
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Middle Aged; Prospective Studies; Ranolazine; Treatment Outcome; Young Adult | 2015 |
Glucose-Lowering Medications and Angina Burden in Patients with Stable Coronary Disease: results from the Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina (TERISA) Trial.
Topics: Aged; Angina, Stable; Blood Glucose; Cardiovascular Agents; Chronic Disease; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypoglycemic Agents; Male; Middle Aged; Ranolazine; Retrospective Studies | 2015 |
Effect of ranolazine on glycaemic control in patients with type 2 diabetes treated with either glimepiride or metformin.
Topics: Aged; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Interactions; Drug Monitoring; Drug Resistance; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Male; Metformin; Middle Aged; Ranolazine; Sodium Channel Blockers; Sulfonylurea Compounds | 2016 |
Pharmacokinetic drug-drug interaction study of ranolazine and metformin in subjects with type 2 diabetes mellitus.
Topics: Adult; Aged; Angina Pectoris; Animals; Area Under Curve; Cardiovascular Agents; CHO Cells; Chronic Disease; Comorbidity; Cricetulus; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Interactions; Female; Humans; Hypoglycemic Agents; Male; Metabolic Clearance Rate; Metformin; Middle Aged; Organic Cation Transporter 2; Polypharmacy; Ranolazine; United States | 2015 |
Effect of ranolazine on arterial endothelial function in patients with type 2 diabetes mellitus.
Topics: Acetanilides; Arteries; Diabetes Mellitus, Type 2; Endothelium, Vascular; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Piperazines; Ranolazine; Single-Blind Method | 2013 |
9 other study(ies) available for ranolazine and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
The anti-anginal ranolazine does not confer beneficial actions against hepatic steatosis in male mice subjected to high-fat diet and streptozotocin-induced type 2 diabetes.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; Diet, High-Fat; Insulin Resistance; Liver; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Obesity; Ranolazine; Streptozocin; Triglycerides | 2022 |
Ranolazine Attenuates Brain Inflammation in a Rat Model of Type 2 Diabetes.
Topics: Animals; Diabetes Mellitus, Type 2; Diet, High-Fat; Encephalitis; Metformin; Noncommunicable Diseases; Ranolazine; Rats; Streptozocin | 2022 |
Improvement of Vascular Insulin Sensitivity by Ranolazine.
Topics: Adrenergic Agents; Animals; Aorta, Abdominal; Diabetes Mellitus, Type 2; Insulin Resistance; Rabbits; Ranolazine; Vasodilator Agents | 2023 |
Ranolazine in patients with type 2 diabetes and chronic angina: A cost-effectiveness analysis and assessment of health-related quality-of-life.
Topics: Angina, Stable; Cardiovascular Agents; Cohort Studies; Cost-Benefit Analysis; Diabetes Mellitus, Type 2; Female; Humans; Male; Markov Chains; Prospective Studies; Quality of Life; Ranolazine | 2018 |
Diabetes and coronary disease: a need for new therapies for an expanding disease burden.
Topics: Acetanilides; Angina, Stable; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Female; Humans; Male; Piperazines; Ranolazine; Sodium Channel Blockers | 2013 |
[The TERISA study].
Topics: Acetanilides; Angina Pectoris; Diabetes Complications; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Humans; Piperazines; Randomized Controlled Trials as Topic; Ranolazine | 2013 |
Comparative Effectiveness of Ranolazine Versus Traditional Therapies in Chronic Stable Angina Pectoris and Concomitant Diabetes Mellitus and Impact on Health Care Resource Utilization and Cardiac Interventions.
Topics: Adrenergic beta-Antagonists; Aged; Angina, Stable; Calcium Channel Blockers; Cardiovascular Agents; Chronic Disease; Comparative Effectiveness Research; Cost-Benefit Analysis; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Health Resources; Humans; Male; Nitroglycerin; Ranolazine; Retrospective Studies; Risk Factors; Treatment Outcome; United States; Vasodilator Agents | 2015 |
Ranolazine improves insulin resistance in non-diabetic patients with coronary heart disease. A pilot study.
Topics: Adult; Aged; Aged, 80 and over; Cardiovascular Agents; Coronary Disease; Diabetes Mellitus, Type 2; Exercise Test; Female; Follow-Up Studies; Humans; Insulin Resistance; Male; Middle Aged; Obesity; Pilot Projects; Ranolazine | 2016 |
Metabolic agents in the management of diabetic coronary patients: a new era.
Topics: Acetanilides; Citric Acid Cycle; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dichloroacetic Acid; Enzyme Inhibitors; Epoxy Compounds; Humans; Insulin Resistance; Perhexiline; Piperazines; Ranolazine; Trimetazidine; Vasodilator Agents | 2008 |